Insider · CIK 0001969518
Peter John Ratcliffe
Files at IMCR (Immunocore Holdings plc). First filing -, latest -.
Peter John Ratcliffe files SEC Form 4 as director at IMCR (Immunocore Holdings plc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Peter John Ratcliffe has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | IMCR Immunocore Holdings plc | AGrant or award Share Option (Right to Buy)derivative | +26,198 | $0.00 | $0 | 26,198 | May 19, 2025 |
Questions about Peter John Ratcliffe
Answered from the filings on this page, as of the latest one.
Is Peter John Ratcliffe buying or selling?
Peter John Ratcliffe has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Peter John Ratcliffe's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter John Ratcliffe has 0.
Where does Peter John Ratcliffe file Form 4?
Peter John Ratcliffe has filed Form 4 at IMCR (Immunocore Holdings plc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.